Christopher Richard Anzalone

Chief Executive Officer, Director, Arrowhead Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$24.0M

Companies

Latest trade

Jan 2, 2026

Companies

Arrowhead PharmaceuticalsChief Executive Officer, Director −$24.0M

Trades

ARWR Sold 13,187 shares at $66.10 · planned $0.9M Jan 2

ARWR Sold 51,726 shares at $69.13 · planned $3.6M Dec 29

ARWR Sold 12,586 shares at $68.44 · planned $0.9M Dec 22

ARWR Sold 13,445 shares at $67.66 · planned $0.9M Dec 19

ARWR Sold 85,000 shares at $64.04 $5.4M Dec 17

ARWR Sold 54,298 shares at $62.58 $3.4M Dec 16

ARWR Sold 130,000 shares at $68.85 $9.0M Dec 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.